can you use tirzepatide while breastfeeding Breastfeeding: Safety & Guidelines Tirzepatide and Breastfeeding: Safety Guide

Do you think your results would have been different without the accountability and guidance

Gastrointestinal symptoms like nausea, vomiting, and diarrhoea are most common during the initial weeks of Mounjaro treatment

ESTABLISHED PHARMACOLOGICAL LANDSCAPE SGLT2i For decades, the management of HFpEF has focused on managing comorbidities and symptoms, mainly with diuretics.14, 53) Only recently, the therapeutic landscape has evolved with the introduction of SGLT2i, which have demonstrated consistent benefits in patients with HF across the EF spectrum, including those with worsening or acute HF.21, 56, 57, 58) Initially developed for the treatment of type 2 diabetes, these agents were later found to improve hard cardiovascular outcomes in HFrEF, including a reduction in HF hospitalisations and, unexpectedly, cardiovascular death.17, 18) In parallel, SGLT2i have also been shown to slow kidney function decline and improve renal and HF outcomes in patients with CKD

"I don't do anything carbonated," says Tamara, who mostly drinks still water enhanced with electrolytes

Comparison of the cardiorenal effects between combination therapy and monotherapy with SGLT2i or GLP1ra

Mounjaro is classified as a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist